APA (7th ed.) Citation

Rodríguez‐Álvarez, Y., Cabrales‐Rico, A., Perera‐Pintado, A., Prats‐Capote, A., Garay‐Pérez, H. E., Reyes‐Acosta, O., . . . Santos‐Savio, A. (2018). <italic>In vitro</italic> and <italic>in vivo</italic> characterization of an interleukin‐15 antagonist peptide by metabolic stability, 99mTc‐labeling, and biological activity assays. Journal of peptide science: an official publication of the European Peptide Society, 24, 1. https://doi.org/10.1002/psc.3078

Chicago Style (17th ed.) Citation

Rodríguez‐Álvarez, Yunier, Ania Cabrales‐Rico, Alejandro Perera‐Pintado, Anais Prats‐Capote, Hilda E. Garay‐Pérez, Osvaldo Reyes‐Acosta, Erik Pérez‐García, Araceli Chico‐Capote, and Alicia Santos‐Savio. "In Vitro and in Vivo Characterization of an Interleukin‐15 Antagonist Peptide by Metabolic Stability, 99mTc‐labeling, and Biological Activity Assays." Journal of Peptide Science: An Official Publication of the European Peptide Society 24 (2018): 1. https://doi.org/10.1002/psc.3078.

MLA (9th ed.) Citation

Rodríguez‐Álvarez, Yunier, et al. "In Vitro and in Vivo Characterization of an Interleukin‐15 Antagonist Peptide by Metabolic Stability, 99mTc‐labeling, and Biological Activity Assays." Journal of Peptide Science: An Official Publication of the European Peptide Society, vol. 24, 2018, p. 1, https://doi.org/10.1002/psc.3078.